Cart
sales@molnova.com
Coumarin VI
CAS No. 38215-36-0
Coumarin VI( Coumarin 6 )
Catalog No. M24341 CAS No. 38215-36-0
Coumarin VI is a fluorescent dye frequently used to facilitate the traceability of drug delivery systems in vitro.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 50MG | 31 | In Stock |
|
| 100MG | 39 | In Stock |
|
| 200MG | 56 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCoumarin VI
-
NoteResearch use only, not for human use.
-
Brief DescriptionCoumarin VI is a fluorescent dye frequently used to facilitate the traceability of drug delivery systems in vitro.
-
DescriptionCoumarin VI is a fluorescent dye frequently used to facilitate the traceability of drug delivery systems in vitro.
-
In Vitro——
-
In Vivo——
-
SynonymsCoumarin 6
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number38215-36-0
-
Formula Weight350.44
-
Molecular FormulaC20H18N2O2S
-
Purity>98% (HPLC)
-
SolubilityDMSO:5 mg/mL (14.27 mM; Need ultrasonic)
-
SMILESCCN(CC)c(cc1)cc(O2)c1C=C(c1nc(cccc3)c3s1)C2=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Coumarin 6 and 1,6-diphenyl-1,3,5-hexatriene (DPH) as fluorescent probes to monitor protein aggregation.Analyst. 2011 May 21;136(10):2161-7.
molnova catalog
related products
-
Glyoxylic acid monoh...
Glyoxylic acid or oxoacetic acid is an organic compound that is both an aldehyde and a carboxylic acid.It is an intermediate of the glyoxylate cycle which enables certain organisms to convert fatty acids into carbohydrates. The conjugate base of glyoxylic acid is known as glyoxylate.
-
Kuwanon W
Kuwanon W is a natural product that can be isolated from the root bark of Morus lhou.
-
Concizumab
Concizumab is an anti-TFPI monoclonal antibody (IgG4 type) that selectively binds to the Kunitz protease inhibitor (KPI) 2 domain of TFPI, blocking its interaction with the FXa active site.
